Company ProfilePremium

Zoetis

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Zoetis - Healthcare showcase

Year Founded & Workforce

1952

9,200 Employees

Industry

Healthcare

Services

Pain Management: CatPain Management: Dog
Z

Zoetis Employee Contacts

313 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Zoetis Overview

Company Headquarters: Parsippany, New Jersey, United States

Founded: 1952

Workforce: 9200+

Company Working: Zoetis is a global animal health company that manufactures, develops, and commercializes pharmaceutical and biological products for animals. It operates through the anti-infectives, vaccines, parasiticides, medicated feed additives, other pharmaceuticals, and other non-pharmaceuticals business segments. It manufactures products for cattle, swine, poultry, fish, and other livestock and companion animals. Zoetis has a wide range of products which provide effective treatment for the animals, and it operates in all the major markets as well as in the developing countries. The company markets more than 200 approved products worldwide.

Strategy

Zoetis focuses on increasing its global presence by establishing its manufacturing, R&D, and commercial operations in various regions across the world. To increase sales and marketing, Zoetis emphasizes targeted activities, that include direct-to-consumer advertising to increase consumer awareness about its products.

Company Snapshot

$4,765M

Revenue

9,200

Employees

1952

Founded

Parsippany, New Jersey, United States

Headquarters

SWOT Analysis

Strengths

  • Strong capabilities to create strategic alliances and marketing partnerships
  • Well-developed in-house R&D capabilities
  • Wide geographic presence

Weaknesses

  • Price wars with competitors

Opportunities

  • Formulation of innovative products
  • Collaborative research on the medical industry

Threats

  • Government regulations
  • Economic recession
  • Competition from local players
  • Distribution of products on credit basis would prove to be a threat for the company

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Zoetis
    • Pain Management: Cat
    • Pain Management: Dog

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 6,675 Mn in 2020 to USD 8,080 Mn in 2022.
Zoetis — By Business Segment
Series (USD Mn)202020212022
Sales6,6757,7768,080
R&D463508539

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.